Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • renuka22
    Member
    • Mar 2017
    • 22

    #1

    RNA seq bioinformatics

    Hello all,

    I have RNA seq data from 2 replicates of control and treated (say for example C1,C2,T1,T2). But when I compared the replicates separately (C1vsT1) ,(C2vsT2) there were around 1500 differentially expressed genes, but when the company combined the replicates together (all control C1C2 together vs T1T2 together) the differentially expressed genes were around 160 only. Also, the differentially expressed genes which showed up for combined replicates were different than the ones in C1TI or C2T2. Could anyone tell me what might be the reason for this?

    Thanks
  • Biocomputronics
    Junior Member
    • Sep 2017
    • 6

    #2
    It all depends on how you are doing the test for differential gene expression. But the basic idea is around statistical power and significance. Generally speaking, you cannot compare one replicate for treatment A with one replicate for treatment B since you have zero statistical power. Even 2 replicates is generally considered not enough since there is a lot of biological and technical variation involved. Most people suggest at least 3 replicates per condition. Then you need to use a principled statistical method to determine differential expression such as the one's incorporated in the packages edgeR or DESeq2. You can't really use simplistic tests like a t-test with RNA-seq data.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...